Estrogen therapy avoidance possible factor in nearly 50,000 deaths

07/22/2013 | HealthDay News · CBS News

A study published in the American Journal of Public Health found that avoidance of estrogen hormonal therapy was a possible factor in the deaths of almost 50,000 women who had hysterectomies and experienced menopausal symptoms over the past decade. Researchers analyzed U.S. Census data and found that the use of hormone therapy fell significantly after the publication of the 2002 U.S. Women's Health Initiative Study, which linked estrogen-progestin combination therapy to higher risk of breast cancer, heart disease, stroke and blood clots. "Sadly, the media, women, and health care providers did not appreciate the difference between [estrogen-only and estrogen-plus-progestin] hormone therapy," said health expert Dr. Philip Sarrel.

View Full Article in:

HealthDay News · CBS News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC